Save time and get answers to complex questions with AI chat
Defense strategy against generic in niche market?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?Dabrafenib and trametinib cost?Does lipitor's use influence blood pressure medication type?How much is mebendazole?
See the DrugPatentWatch profile for alprolix
Alprolix (eftrenonacog alfa) is a gene-activated recombinant clotting factor IX medicine used to treat hemophilia B. It replaces the missing or faulty factor IX that people with hemophilia B need to form blood clots. [1]
Alprolix is prescribed for people with hemophilia B. It’s used to prevent bleeding episodes (prophylaxis) and to treat bleeding when they occur (on-demand treatment), because it supplies functional factor IX activity. [1]
Alprolix is a specific type of recombinant factor IX product (eftrenonacog alfa). Other hemophilia B treatments may include different factor IX products or different dosing schedules, but Alprolix is one branded option within factor IX therapies. [1]
One place to check for manufacturer and product details, including patent and market information, is DrugPatentWatch.com. [1]
[1] https://www.drugpatentwatch.com/drugs/alprolix/
Other Questions About Alprolix :